Sana Biotechnology, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-421.2M | $124.8M |
| FY2021 | — | $728.5M | $253.0M |
| FY2022 | — | $499.3M | $176.8M |
| FY2023 | — | $287.5M | $133.5M |
| FY2024 | — | $250.5M | $127.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-421.2M | $124.8M |
| FY2021 | — | $728.5M | $253.0M |
| FY2022 | — | $499.3M | $176.8M |
| FY2023 | — | $287.5M | $133.5M |
| FY2024 | — | $250.5M | $127.6M |